More than 80 global executives gathered in Beijing for the China Development Forum, signaling renewed corporate interest in the Chinese market despite ongoing geopolitical tensions.

Leaders from major multinationals, including Apple Inc. (NASDAQ:AAPL) and Eli Lilly and Co. (NYSE:LLY), emphasized opportunities tied to China's consumer base following years of disruption from the COVID-19 pandemic, economic slowdown, and trade frictions.

The discussions reflected a cautious but clear pivot toward expansion, as Beijing continues to gradually ease restrictions on foreign businesses.

Eli Lilly Expands China Bet With Obesity Drug Focus

In March, Eli Lilly outlined an aggressive long-term strategy for China, announcing plans to invest $3 billion in the country over the next decade. The move comes as the company looks to scale its presence in a market that contributed less than 3% of its revenue last year.

David A. Ricks, the company's ...